The financials
IRADIMED CORPORATION by the numbers
IRADIMED CORPORATION (IRMD) reported revenue of $22M in Q1 2026 (quarter ended Mar 31, 2026), up 13% from the same quarter a year earlier. That came with a gross margin of 77% and net income of $5.8M (26% of revenue). For the full year FY2025, revenue was $84M (+14% year on year) and net income $22M. Its largest region in Jun 2026 was United States at $17M, 82% of the disclosed total, well ahead of Non Us at 18%.
| Income statement | Q1 2026 | Q1 2025 | Change |
|---|---|---|---|
| Revenue | $22M | $20M | +13% |
| Gross profit | $17M | $15M | +13% |
| Operating income | $7.2M | $5.4M | +33% |
| Net income | $5.8M | $4.7M | +24% |
| Diluted EPS | $0.45 | $0.37 | +22% |
| Geographic | Revenue | Share |
|---|---|---|
| United States | $17M | 82% |
| Non Us | $3.7M | 18% |
Business Segments
Revenue split by geographic segment, from SEC XBRL filings.
Latest period: Jun 2026Total $20.5M (-6.9%)
Non Us grew +69% year on yearUnited States -8.1% year on year
Segment Latestquarter on quarteryear on year
- United States$16.7M$16.7MQoQ -7.2%year on year -8.1%-7.2%-8.1%
- Non Us$3.7M$3.7MQoQ -5.3%year on year +69%-5.3%+69%